Public Board of Directors papers 29.09.22

Agenda item 30/22a

Meeting of the Board of Directors Thursday 29 th September 2022

Quality Assurance Committee Report – June 2022

1

Introduction The Quality Assurance Committee took place on 23 rd June 2022. The following summary gives the Board information on the items that were considered, and any actions required by the Board.

2

Quality Assurance Committee agenda items The items listed below were all presented to the Quality Assurance Committee for assurance in June:

Agenda item

Associated action (where applicable) and/or comments to note No actions identified during meeting. Noted that the number of corporate key risks has reduced to 4. Questions raised in relation to progress with Digital programme; confirmed that CIO attending Board in June. No actions identified during meeting. Progress to be monitored through Committee. No actions identified during meeting. Consideration to be given to broaden the communication to the public. No actions identified during meeting. No actions identified during meeting. Consideration to be given to the use of protected characteristics data. Hand hygiene audits to take a focus and audit data to be expanded for future reports to include number of audits performed. No actions identified during meeting. Audit on clinical research facility to be covered as part of Board Time Out in July. No actions identified during meeting. Ongoing challenges with changes to

BAF reference

Assurance rating given

Briefing from the Risk and Quality Governance Committee

N/A

N/A

Quality strategy & implementation plan 2022-2025

N/A

N/A

Quality report 2021-22

N/A

N/A

Serious incident panels Q4 2021-22 Learning from deaths - Inpatient mortality reviews at the Christie 2021- 22 Infection prevention and control (IPC) annual report 2021-22

1.2 N/A

High

N/A

1.1

High

Annual clinical audit plan

N/A

N/A

Consent practice / audit

N/A

N/A

12